Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    lymphoma [CONDITION] | Open Studies | genetic | Canada
Show Display Options
Rank Status Study
1 Recruiting Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients
Condition: Diffuse Large B-cell Lymphoma (DLBCL)
Intervention: Genetic: CTL019
2 Recruiting Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)
Condition: Anaplastic Lymphoma Kinase (ALK)
Intervention: Drug: LDK378
3 Recruiting Determine Efficacy and Safety of CTL019 in Pediatric Patients With Relapsed and Refractory B-cell ALL
Condition: Lymphoblastic Leukemia, Acute, Childhood
Intervention: Genetic: Single dose of CTL019
4 Recruiting Collecting and Storing Tissue From Young Patients With Cancer
Condition: Cancer
Interventions: Genetic: DNA analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: biologic sample preservation procedure;   Other: flow cytometry;   Other: laboratory biomarker analysis

Study has passed its completion date and status has not been verified in more than two years.